Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The study aims at determining the feasibility of using maintenance Decitabine therapy
following remission induction and consolidation in elderly Acute Myeloid Leukemia patients
who are fit for aggressive therapy.
Primary: Safety and tolerability of the decitabine regimen in the post remission state.
Secondary:
1. Disease-free survival - To determine the one-year disease-free survival in elderly
patients with acute myeloid leukemia (AML) in complete remission treated with Decitabine
as post-consolidation maintenance therapy.
2. Overall survival